Wild-type (senile) amyloidosis other imaging findings: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Wild-type (senile) amyloidosis}} {{CMG}} ==Overview== ==Other Imaging Findings== ==References== {{Reflist|2}} Category:Disease Category:Cardiology Ca...") |
No edit summary |
||
| Line 6: | Line 6: | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
===Nuclear Imaging=== | |||
*Bone-avid tracers, such as 99mTc-DPD (technetium-3,3-diphosphono-1,2-propanodicar-boxylic acid), 99mTc-PYP (technetium-pyrophosphate), and 99mTc-HMDP [technetium-hydroxymethylene diphosphonate (Tc-HMDP)] have been implicated to have high sensitivity and specificity for diagnosing cardiac amyloidosis and differentiating it from other cardiomyopathies with HFpEF.<ref>{{Cite journal | |||
| author = [[Enrica Perugini]], [[Pier Luigi Guidalotti]], [[Fabrizio Salvi]], [[Robin M. T. Cooke]], [[Cinzia Pettinato]], [[Letizia Riva]], [[Ornella Leone]], [[Mohsen Farsad]], [[Paolo Ciliberti]], [[Letizia Bacchi-Reggiani]], [[Francesco Fallani]], [[Angelo Branzi]] & [[Claudio Rapezzi]] | |||
| title = Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy | |||
| journal = [[Journal of the American College of Cardiology]] | |||
| volume = 46 | |||
| issue = 6 | |||
| pages = 1076–1084 | |||
| year = 2005 | |||
| month = September | |||
| doi = 10.1016/j.jacc.2005.05.073 | |||
| pmid = 16168294 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Sabahat Bokhari]], [[Rachelle Morgenstern]], [[Richard Weinberg]], [[Mona Kinkhabwala]], [[Demetrios Panagiotou]], [[Adam Castano]], [[Albert DeLuca]], [[Andrew Kontak]], [[Zhezhen Jin]] & [[Mathew S. Maurer]] | |||
| title = Standardization of (99m)Technetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis | |||
| journal = [[Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology]] | |||
| volume = 25 | |||
| issue = 1 | |||
| pages = 181–190 | |||
| year = 2018 | |||
| month = February | |||
| doi = 10.1007/s12350-016-0610-4 | |||
| pmid = 27580616 | |||
}}</ref> | |||
==References== | ==References== | ||
Revision as of 18:39, 19 December 2019
|
Wild-type (senile) amyloidosis Microchapters |
|
Differentiating Wild-type (senile) amyloidosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Wild-type (senile) amyloidosis other imaging findings On the Web |
|
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis other imaging findings |
|
FDA on Wild-type (senile) amyloidosis other imaging findings |
|
CDC on Wild-type (senile) amyloidosis other imaging findings |
|
Wild-type (senile) amyloidosis other imaging findings in the news |
|
Blogs on Wild-type (senile) amyloidosis other imaging findings |
|
Risk calculators and risk factors for Wild-type (senile) amyloidosis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other Imaging Findings
Nuclear Imaging
- Bone-avid tracers, such as 99mTc-DPD (technetium-3,3-diphosphono-1,2-propanodicar-boxylic acid), 99mTc-PYP (technetium-pyrophosphate), and 99mTc-HMDP [technetium-hydroxymethylene diphosphonate (Tc-HMDP)] have been implicated to have high sensitivity and specificity for diagnosing cardiac amyloidosis and differentiating it from other cardiomyopathies with HFpEF.[1][2]
References
- ↑ Enrica Perugini, Pier Luigi Guidalotti, Fabrizio Salvi, Robin M. T. Cooke, Cinzia Pettinato, Letizia Riva, Ornella Leone, Mohsen Farsad, Paolo Ciliberti, Letizia Bacchi-Reggiani, Francesco Fallani, Angelo Branzi & Claudio Rapezzi (2005). "Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy". Journal of the American College of Cardiology. 46 (6): 1076–1084. doi:10.1016/j.jacc.2005.05.073. PMID 16168294. Unknown parameter
|month=ignored (help) - ↑ Sabahat Bokhari, Rachelle Morgenstern, Richard Weinberg, Mona Kinkhabwala, Demetrios Panagiotou, Adam Castano, Albert DeLuca, Andrew Kontak, Zhezhen Jin & Mathew S. Maurer (2018). "Standardization of (99m)Technetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis". Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 25 (1): 181–190. doi:10.1007/s12350-016-0610-4. PMID 27580616. Unknown parameter
|month=ignored (help)